Back to 
AMERIPRISE FINANCIAL INC
AMERIPRISE FINANCIAL INC
SABS3 quarters
Position history for AMERIPRISE FINANCIAL INC's holdings in SAB BIOTHERAPEUTICS INC
Yes. Ameriprise Financial holds 611,019 shares of SABS (Sab Biotherapeutics), worth $2.4M, as of its Q2 2026 13F filing. It reduced the position by 865,087 shares (-58.6%) from Q1 2026. Ameriprise Financial has held SABS since Q4 2025, across 3 quarterly 13F filings.
Current Value
$2.4M
Current Shares
611,019
Total Value Change
+$1.3M
Total Shares Change
+327,374
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.